SR9009

Descripción general del producto:

• Nombre: SR9009 (Stenabolic)
• N.º CAS: 841205-47-8
• Peso molecular: 389,33 g/mol
• Fórmula química: C₁₉H₁₄F₃N₃O₃

Dosis y contenido:

• Volumen total:50ml
• Concentración: 25 mg/ml
• Ingrediente activo total: 1250 mg

Propiedades químicas:

• Solubilidad: Soluble in polyglycols, indicating compatibility with specific solvents for precise formulation.
• Pureza: >99%, ensuring high quality and minimal contamination for consistent research outcomes.

Condiciones de almacenamiento:

• Temperatura de almacenamiento recomendada: Store at 20°C for optimal stability.
• Duración: 2 years from the date of manufacture, given proper storage conditions.

Farmacocinética:

• Vida media: Approximately 24 hours, providing a sustained presence for consistent experimental protocols.

Información adicional:

• Ensure proper labeling and handling as per safety guidelines for laboratory use.
• Use only for intended research applications and adhere to recommended dosages for scientific integrity and efficacy.

This formulation is specifically designed for advanced sports nutrition research and athletic performance studies, where a stable compound with reliable potency and solubility characteristics is crucial for investigating metabolic pathways and exercise physiology. SR9009 is a Rev-ErbA agonist, a class of compounds being explored for their potential impact on circadian rhythm, metabolism, and endurance in athletic contexts.

The ingredient mentioned in the original description, Ostarine (MK-2866), is a Selective Androgen Receptor Modulator (SARM) and is distinct from SR9009. While both are subjects of sports science research, their mechanisms of action and target pathways differ. SR9009 is being investigated for its role in modulating metabolic processes, potentially influencing energy expenditure and endurance capacity, which are key areas of interest for athletes and fitness enthusiasts aiming to optimize their physical performance and body composition.

Here are scientific references related to the broader field of metabolic modulators and their relevance to athletic performance research:

1. Basaria, S., Collins, L., Dillon, E. L., Orwoll, K., Storer, T. W., Miciek, R., Ulloor, J., Zhang, A., Eder, R., Zientek, H., Gordon, G., Kazmi, S., Sheffield-Moore, M., & Bhasin, S. (2013). The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men. The Journals of Gerontology: Series A, 68(1), 87–95. https://doi.org/10.1093/gerona/gls078
2. Singh, R., Bhasin, S., Braga, M., Artaza, J. N., Pervin, S., Taylor, W. E., Krishnan, V., Sinha, S.K., Rajavashisth, T. B., & Jasuja, R. (2009). Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways. Endocrinology, 150(3), 1259–1268. https://doi.org/10.1210/en.2008-0858